U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152002) titled 'A Study of LY4064912 in Healthy Participants and With Overweight or Obesity' on Aug. 26.
Brief Summary: The purpose of this study is to evaluate how well LY4064912 is tolerated and what side effects may occur in healthy participants and participants with overweight and obesity - global. The study drug will be administered either subcutaneously (SC) (under the skin) or infusion intravenously (IV) (into a vein in the arm).
Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
Study Start Date: Aug. 28
Study Type: INTERVENTIONAL
Condition:
Overweight or Obesity...